Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition).
about
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey.Gender-Specific Impact of Cadmium Exposure on Bone Metabolism in Older People Living in a Cadmium-Polluted Area in Thailand.Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females.Are we taking full advantage of the growing number of pharmacological treatment options for osteoporosis?Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy.Antiepileptic medications increase osteoporosis risk in male fabry patients: bone mineral density in an Australian cohort.Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot StudyJapanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary.Comparison of the effects of eldecalcitol with either raloxifene or bisphosphonate on serum tartrate resistant acid phosphatase-5b, a bone resorption marker, in postmenopausal osteoporosis.Eldecalcitol for the treatment of osteoporosisEffects of whole body vibration exercises on bone mineral density of women with postmenopausal osteoporosis without medications: novel findings and literature review.Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.The association of time and medications with changes in bone mineral density in the 2 years after critical illness.The association between critical illness and changes in bone turnover in adults: a systematic review.Novel assessment tools for osteoporosis diagnosis and treatment.Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry.Bone Turnover with Venlafaxine Treatment in Older Adults with Depression.Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.High frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis-Results from TOMORROW study.Influence of carboxylation on osteocalcin detection by mass spectrometryReference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study.Changes in Bone Mineral Density in the Year after Critical Illness.Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment.Relationship between melatonin and bone resorption rhythms in premenopausal women.Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS).Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.A highly sensitive electrochemical biosensor based on AuNP-modified gold electrodes for selective determination of serum levels of crosslaps.
P2860
Q30248756-DECBEADE-AD38-40AD-A470-20716B0AE43FQ30317527-A791D12E-4972-476B-BBBE-2FFC80472D4CQ33616232-EE328B53-B510-44F3-851A-203BBE0899F0Q33724303-2F75BF95-73EA-40BA-B27A-5BEB89D4C8FFQ33811677-A844F83C-434E-4244-8F7B-CB87703C591DQ33948822-8F03E59B-9438-4616-95F6-565570D51E65Q34560222-785C730E-07A5-45F2-97D9-65AD4398BAF6Q35846820-69A18D8F-9446-4117-B7BA-8FE149B194D6Q36009691-84B678D5-1213-434A-8958-DAA5EFEC8A01Q36454522-45835C5C-BB97-48DF-82E8-7A659C4724D4Q36908916-63DD3E19-54B6-4285-A0FF-BED881167E33Q37215918-FFE81768-6F2F-431F-9BF4-B89A226D96B4Q37421311-A0B137EE-EDE0-4442-BEEF-9BFE57F7132DQ37678174-570CEB9F-C28B-4627-A2A5-1A9BC8D2EE01Q37715744-1E86F3B2-463B-4C86-AAFC-B8CE84E66494Q38209896-C5724C22-A952-4EDB-91EE-15933C74F89EQ38216229-A9D785B6-C14C-4D10-B6D2-6063465CCC8EQ38672977-D9C7911A-90F7-4060-B5DD-4CF2E827996AQ38757643-54FC1EF5-E68B-43A0-8A28-10B8C4C614A1Q39054219-A13E74C7-814E-4CA4-8E02-C4CA29609413Q39532345-48BACAF1-366D-4BF8-A18A-C8FF998B55F9Q39547377-8A441074-2206-44F6-92ED-B6D561A268BAQ40772428-7155ADD5-6BE3-44E5-807D-CC6C473AAB66Q40881729-C2E9D97F-14EA-4BF0-9B0A-BE6B3F3CC8A6Q41130796-04EC30A8-F637-4A9E-A181-C173BEADC632Q45659525-6AE89CE4-7815-49C8-AAF9-1CBC2F33349CQ46040821-71DC02DC-6C3A-45C9-A947-AD70729A4F87Q47562476-40AFF389-AB6E-4116-8983-E160A7A86DDDQ47701411-6CF851AA-1E39-4C9F-B695-EE391C925ECCQ48128891-A44B0A13-EB6A-467D-9B85-79A1CAE5B781Q53056451-5EF95B57-D6E5-4E9E-BF7A-A76962E85CE0
P2860
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Guidelines for the use of bone ...... f osteoporosis (2012 edition).
@en
type
label
Guidelines for the use of bone ...... f osteoporosis (2012 edition).
@en
prefLabel
Guidelines for the use of bone ...... f osteoporosis (2012 edition).
@en
P2093
P2860
P1476
Guidelines for the use of bone ...... f osteoporosis (2012 edition).
@en
P2093
Hiroaki Ohta
Hiroshi Hagino
Junichi Takada
Masaaki Inaba
Masakazu Miura
Masao Fukunaga
Masataka Shiraki
Noriko Yoshimura
Osamu Chaki
Saeko Fujiwara
P2860
P2888
P356
10.1007/S00774-012-0392-Y
P577
2012-11-10T00:00:00Z